Novel 1-phenylpiperazine and 4-phenylpiperidine derivatives as high-affinity sigma ligands. 1991

R A Glennon, and M Y Yousif, and A M Ismaiel, and M B el-Ashmawy, and J L Herndon, and J B Fischer, and A C Server, and K J Howie
Department of Medicinal Chemistry, School of Pharmacy, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0540.

sigma receptors may represent an exciting new approach for the development of novel psychotherapeutic agents. Unfortunately, many of the commonly used sigma ligands lack selectivity (e.g., many bind at phencyclidine or dopamine receptors) or suffer from other serious drawbacks. Recently, we described a series of 2-phenylaminoethanes that bind at sigma receptors with high affinity and selectivity. Because there is evidence that 1-phenylpiperazines can structurally mimic the 2-phenylaminoethane moiety, we prepared a series of 1-phenylpiperazines and related analogues and incorporated structural features already shown to enhance the sigma binding of the 2-phenylaminoethanes. Several of these derivatives bind at sigma receptors with high affinity (Ki = 1-10 nM) and lack appreciable affinity for phencyclidine and dopamine receptors. In as much as certain of these agents structurally resemble the high-affinity, but nonselective, sigma ligand haloperidol, and because they bind with 10 times the affinity of haloperidol, we have apparently identified what appears to be the primary sigma pharmacophore of that agent.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D010880 Piperidines A family of hexahydropyridines.
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D011957 Receptors, Opioid Cell membrane proteins that bind opioids and trigger intracellular changes which influence the behavior of cells. The endogenous ligands for opioid receptors in mammals include three families of peptides, the enkephalins, endorphins, and dynorphins. The receptor classes include mu, delta, and kappa receptors. Sigma receptors bind several psychoactive substances, including certain opioids, but their endogenous ligands are not known. Endorphin Receptors,Enkephalin Receptors,Narcotic Receptors,Opioid Receptors,Receptors, Endorphin,Receptors, Enkephalin,Receptors, Narcotic,Receptors, Opiate,Endorphin Receptor,Enkephalin Receptor,Normorphine Receptors,Opiate Receptor,Opiate Receptors,Opioid Receptor,Receptors, Normorphine,Receptors, beta-Endorphin,beta-Endorphin Receptor,Receptor, Endorphin,Receptor, Enkephalin,Receptor, Opiate,Receptor, Opioid,Receptor, beta-Endorphin,Receptors, beta Endorphin,beta Endorphin Receptor,beta-Endorphin Receptors
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D017478 Receptors, Phencyclidine Specific sites or molecular structures on cell membranes or in cells with which phencyclidine reacts or to which it binds to elicit the specific response of the cell to phencyclidine. Studies have demonstrated the presence of multiple receptor sites for PCP. These are the PCP/sigma site, which binds both PCP and psychotomimetic opiates but not certain antipsychotics, and the PCP site, which selectively binds PCP analogs. PCP Receptors,Phencyclidine Receptors,Receptors, PCP,PCP Receptor,Phencylidine Receptor,Receptor, PCP,Receptor, Phencylidine

Related Publications

R A Glennon, and M Y Yousif, and A M Ismaiel, and M B el-Ashmawy, and J L Herndon, and J B Fischer, and A C Server, and K J Howie
January 2015, European journal of medicinal chemistry,
R A Glennon, and M Y Yousif, and A M Ismaiel, and M B el-Ashmawy, and J L Herndon, and J B Fischer, and A C Server, and K J Howie
July 2011, European journal of medicinal chemistry,
R A Glennon, and M Y Yousif, and A M Ismaiel, and M B el-Ashmawy, and J L Herndon, and J B Fischer, and A C Server, and K J Howie
May 1992, Journal of medicinal chemistry,
R A Glennon, and M Y Yousif, and A M Ismaiel, and M B el-Ashmawy, and J L Herndon, and J B Fischer, and A C Server, and K J Howie
June 2008, European journal of medicinal chemistry,
R A Glennon, and M Y Yousif, and A M Ismaiel, and M B el-Ashmawy, and J L Herndon, and J B Fischer, and A C Server, and K J Howie
May 1992, Journal of medicinal chemistry,
R A Glennon, and M Y Yousif, and A M Ismaiel, and M B el-Ashmawy, and J L Herndon, and J B Fischer, and A C Server, and K J Howie
February 2002, Bioorganic & medicinal chemistry letters,
R A Glennon, and M Y Yousif, and A M Ismaiel, and M B el-Ashmawy, and J L Herndon, and J B Fischer, and A C Server, and K J Howie
January 2022, European journal of medicinal chemistry,
R A Glennon, and M Y Yousif, and A M Ismaiel, and M B el-Ashmawy, and J L Herndon, and J B Fischer, and A C Server, and K J Howie
July 2021, International journal of molecular sciences,
R A Glennon, and M Y Yousif, and A M Ismaiel, and M B el-Ashmawy, and J L Herndon, and J B Fischer, and A C Server, and K J Howie
November 1993, Journal of medicinal chemistry,
R A Glennon, and M Y Yousif, and A M Ismaiel, and M B el-Ashmawy, and J L Herndon, and J B Fischer, and A C Server, and K J Howie
February 2010, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!